Specialty Chemical Stock Hits 52-Week-Low After Posting Healthy Q3 Results; Do You Own?

The financial results for the quarter and nine months ending December 31, 2025, have been released by Sudarshan Pharma Industries, a small-cap company in the specialty chemical industry.

The quarterly results show that during Q3FY25 to Q3FY26, net sales rose by 16% to Rs 168.01 crore. In Q3FY26, the firm recorded a net profit of Rs 4.36 crore, up 51% from Q3FY25. In comparison to 9MFY25, the nine-month results showed a 40% rise in net sales to Rs 482.14 crore and a 67% rise in net profit to Rs 12.58 crore. In comparison to FY24, the company's annual statistics showed a rise of 9% in net sales to Rs 505 crore and a 45 per cent spike in net profit to Rs 16 crore in FY25.

After declaring the Q3FY26 financial performance, Sudarshan Pharma shares reached a fresh 52-week-low today, Thursday, 29th January 2026. Over the period from 29 January 2025 to 29 January 2026, Sudarshan Pharma Industries saw a dramatic shift in its stock price, reflecting significant volatility and a shift in investor sentiment. On 29 January 2025, the stock reached a 52-week high of around Rs 43.14, marking strong upside momentum from prior periods and signalling robust buying interest at that time.

However, over the ensuing year, the stock price weakened considerably, and by 29 January 2026 it hit a 52-week low of Rs 18.50, indicating a sharp correction from the highs seen earlier.

This shows a drop of more than 55% from the high to the trough over the same 52-week period, indicating that the stock underperformed compared to its earlier peak and faced substantial selling pressure notwithstanding earlier gains and periods of optimism.

The company manufactures APl, employs individuals to manufacture pharmaceutical products, and trades chemicals and solvents in India. The company works in the specialty chemicals industry.

Sudarshan Pharma is currently trading up 3.63% intraday, according to Trendlyne data. The stock increased 3.04% during the last week. The stock has dropped 52.72% over the last year and 14.86% over the last quarter. Sudarshan Pharma has a market capitalization of Rs 481.32 Cr. as of January 29, 2026.